HC
HY Capital
Venture CapitalModerateHY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.
8
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for HY Capital.
Investment Thesis & Strategy
HY Capital invests in various stages of fintech companies, focusing on early-stage and growth-stage opportunities within the healthcare industry.
Investment Activity
Deals per year over the last 3 years
5
20174
20183
2019Portfolio Companies
Selected investments from their portfolio of 8 companies
A
Abbisko Therapeutics
Biotech · Series B, 2019
3
3D Medicines
Biotech · Series B, 2019
E
Elpiscience
Biotech · Series B, 2019
A
AccuraGen
Biotech · Series B, 2018
E
EpimAb Biotherapeutics
Biotech · Series B, 2018
N
New Horizon Health
Healthcare · Series B, 2018
S
Singlera Genomics
Biotech · Series B, 2018
Z
Zhejiang Weiming Environment Protection
Healthcare · Growth, 2017
V
Vcanbio
Biotech · Series A, 2017
G
GenomiCare
Healthcare · Series A, 2017
I
Invivo Therapeutics
Biotech · Series A, 2017
R
RemeGen
Biotech · Series B, 2017
Frequently Asked Questions
HY Capital focuses on Series A, Series B, Series C+ stage investments.